Normothermic Regional Perfusion
Tuesday, May 16, 2023 - 14:00 to 15:00
After participating in this webinar, the attendee will be able to:
- Understand the techniques used to re-perfuse the heart following declaration of death on circulatory criteria
- Know the advantages of the NRP
- Review the ethical and legal considerations related to NRP
- Provide a framework for defining death that supports a pathway forward
- Identify existing legal misalignments and areas that would benefit from further research
Speakers:
- Pedro Catarino, MD, FRCS • Professor of Cardiac Surgery, Cedars-Sinai Medical Center, Los Angeles, CA
- Alexandra Glazier, JD, MPH • President & CEO, New England Donor Services Inc., Waltham, MA
Moderator:
- Nikole Neidlinger, MD, MBA, FACS • Associate Professor of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI
The AST Education Committee would like to thank the Donation and Transplantation Optimization Community of Practice (DTO COP) for suggesting this topic as part of the T3 webinar series. Learn more about AST's COPs at www.myast.org/cops.
Education Category:
Series category:
T3: Timely Topics in Transplantion
Donate
Donate
Career Center
Career Center
Patient Education
Patient Education
Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.